Evogen Receives U.S. Patent Covering Its Novel Epilepsy Blood Test

Wednesday, September 27, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

--Patent Covers Key Biomarkers in Evogen's EvoScoreDX™ Biomarker-Based Blood Test for Distinguishing Epileptic Seizures; Addresses Major Unmet Need for Better Epilepsy Diagnostics--

Contacts

Evogen Corporate:

Evogen Media:

Richard St. Clair

Barbara Lindheim

[email protected]

[email protected]

212 584-2276



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store